Richard Mayeux researcher
Mayeux, Richard.
VIAF ID: 46831656 (Personal)
Permalink: http://viaf.org/viaf/46831656
Preferred Forms
- 200 _ | ‡a Mayeux ‡b Richard
-
-
- 100 1 _ ‡a Mayeux, Richard
- 100 1 0 ‡a Mayeux, Richard
-
-
- 100 1 _ ‡a Mayeux, Richard
- 100 1 _ ‡a Mayeux, Richard
- 100 1 _ ‡a Mayeux, Richard
-
-
-
- 100 0 _ ‡a Richard Mayeux ‡c researcher
4xx's: Alternate Name Forms (4)
Works
Title | Sources |
---|---|
Alzheimer's disease and related disorders : psychosocial issues for the patient, family, staff, and community | |
The Dementias, 1983 (a.e.) | |
Epidemiology of Alzheimer's disease : from gene to prevention | |
Investigating neurological disease : epidemiology for clinical neurology | |
Pilot association study of the beta-glucocerebrosidase N370S allele and Parkinson's disease in subjects of Jewish ethnicity | |
Plasma homocysteine levels and risk of Alzheimer disease | |
Plasma lipid levels in the elderly are not associated with the risk of mild cognitive impairment | |
Polygenic Overlap Between C-Reactive Protein, Plasma Lipids, and Alzheimer Disease | |
Polygenic risk score of sporadic late-onset Alzheimer's disease reveals a shared architecture with the familial and early-onset forms. | |
Poriomania | |
Possible association between SORL1 and Alzheimer disease? Reanalysing the data of Shibata et al. | |
Preclinical trials in autosomal dominant AD: implementation of the DIAN-TU trial. | |
Preservation of cognitive and functional ability as markers of longevity. | |
Primary care expenditures before the onset of Alzheimer's disease | |
Progression of Extrapyramidal Signs in Alzheimer's Disease: Clinical and Neuropathological Correlates | |
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease | |
Rare Variants Imputation in Admixed Populations: Comparison Across Reference Panels and Bioinformatics Tools | |
Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer's disease families | |
Rarity of the Alzheimer disease-protective APP A673T variant in the United States | |
Reaction time and vigilance in Parkinson's disease. Possible role of altered norepinephrine metabolism. | |
Reappraisal of temporary levodopa withdrawal ("drug holiday") in Parkinson's disease. | |
Reconsidering harbingers of dementia: progression of parietal lobe white matter hyperintensities predicts Alzheimer's disease incidence | |
Reduced prevalence of cognitive impairment in families with exceptional longevity | |
Regional cerebral blood flow in mood disorders. II. Comparison of major depression and Alzheimer's disease. | |
Relation between vascular risk factors and neuropsychological test performance among elderly persons with Alzheimer's disease | |
Relation of higher folate intake to lower risk of Alzheimer disease in the elderly | |
Relation of plasma homocysteine to plasma amyloid beta levels. | |
Relation of plasma lipids to Alzheimer disease and vascular dementia | |
Relationship Between Type 2 Diabetes Mellitus and Cognitive Change in a Multiethnic Elderly Cohort | |
The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function. | |
The relationship of serotonin to depression in Parkinson's disease | |
Relative Rates of Dementia By Multiple Case Definitions, Over Two Prevalence Periods, In Three Sociocultural Groups. | |
Relative risk of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City. | |
Reply | |
Risk of dementia after stroke in a hospitalized cohort: results of a longitudinal study. | |
Risk of dementia in first-degree relatives of patients with Alzheimer's disease and related disorders. | |
The Role of Cardiovascular Risk Factors and Stroke in Familial Alzheimer Disease | |
Role of p73 in Alzheimer disease: lack of association in mouse models or in human cohorts | |
The role of routine laboratory studies and neuroimaging in the diagnosis of dementia: a clinicopathological study | |
Rozpoznanie otępienia spowodowanego chorobą Alzheimera : zalecenia grupy roboczej National Institute on Aging oraz Alzheimer's Association = The diagnosis of dementia due to Alzheimer's disease : recommendations from the National Institute on Aging and Alzheimer's Association workgroup | |
Safety and efficacy of oral physostigmine in the treatment of Alzheimer disease. | |
The Saitohin 'Q7R' polymorphism and tau haplotype in multi-ethnic Alzheimer disease and Parkinson's disease cohorts. | |
Secular Trends in the Incidence of Dementia in a Multi-Ethnic Community | |
Selective decline in memory function among healthy elderly. | |
Sex hormone binding globulin and incident Alzheimer's disease in elderly men and women | |
Shorter telomeres are associated with mortality in those with APOE epsilon4 and dementia. | |
Simple reaction time as a measure of global attention in Alzheimer's disease. | |
SORCS1 alters amyloid precursor protein processing and variants may increase Alzheimer's disease risk | |
Specificity of the fivefold increase in AD in mothers of adults with Down syndrome. | |
Stroke and memory performance in elderly persons without dementia | |
Structural MRI Predictors of Late-Life Cognition Differ Across African Americans, Hispanics, and Whites | |
Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis | |
Synergistic effects of traumatic head injury and apolipoprotein-epsilon 4 in patients with Alzheimer's disease. | |
Systemic iron metabolism and mortality from Parkinson's disease. | |
Telephone assessment of cognitive function in the late-onset Alzheimer's disease family study | |
Tics in a patient with Parkinson's disease | |
Transethnic genome-wide scan identifies novel Alzheimer's disease loci | |
TREM2 and neurodegenerative disease | |
TREM2 is associated with increased risk for Alzheimer's disease in African Americans | |
Ultra-rare mutations in SRCAP segregate in Caribbean Hispanic families with Alzheimer disease | |
Use of genetic variation as biomarkers for Alzheimer's disease | |
Utility of perfusion PET measures to assess neuronal injury in Alzheimer's disease | |
Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease. | |
Validity of family history for the diagnosis of dementia among siblings of patients with late-onset Alzheimer's disease. | |
Validity of self-reported stroke in elderly African Americans, Caribbean Hispanics, and Whites | |
Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans | |
Vascular disease and cognitive impairment | |
WAIS-R subtest profile and cortical perfusion in Alzheimer's disease. | |
Wczesna faza choroby Alzheimera | |
White matter hyperintensities and the mediating role of cerebral amyloid angiopathy in dominantly-inherited Alzheimer's disease. |